REMEDY_exploitation

Document Sample
REMEDY_exploitation Powered By Docstoc
					REMEDY - Support Networks for
 Tissue Engineering in Europe

          Florence
      November 23rd 2004
                                      REMEDY

           Regenerative Medicine - Support Networks
           in Tissue Engineering Innovation Systems

                                        IPS-2001-42155
Consortium:                                                                       Advisory Board:
Association for the Promotion of Biotechnology          Prof. Dr. Dan L. Bader, University of London
Stuttgart / Tuebingen-Neckar/Alb
                                                        Dr Christine Hauskeller, University of Exeter
attempto Service GmbH
                                                        Mr. Hanspeter Hassenbach, BMBF
Coordinationcentre Clinical Studies of the University
                                                        Dr Hanspeter Schneider, MDS
Hospital Tuebingen gGmbH
                                                        Dr Eszter Tanczos, BioTissue
Fraunhofer Society
                                                        Dr Gudrun Tiedemann, BPI
Interdepartmental Centre for Ethics in the Sciences
and Humanities, University Tuebingen                    Dr Richard Moore, EUCOMED
International Foundation for Regenerative Medicine
Region Skåne
Tartu Biotechnology Park Ltd.
Tissue Engineering Platforms
            REMEDY
    Overall Project objectives

     Identification and analysis of non-technical
     innovation barriers



     Development of tools for overcoming the
     barriers



     Creation of support networks for SMEs in
     tissue engineering




2
                  REMEDY
     Definition & Implementation Phase


Demonstration                   Implementation
Model                           of model,
development                     Germany
(Definition phase               (Implementation phase I
months 1-6)                     months 7-18)
                    REMED
                       Y

Accompanying                    Transfer
Research                        of adapted model;
(Implementation                 Estonia, Sweden
phase I & II                    (Implementation phase II
months 7-30)                    months 19-30)



                            7
                                             REMEDY
                                            Exploitation

Type of result            Impact/ Benefit                               Target user

Expert-network            Improved consulting services; reduction of    SME’s, REMEDY partners and their specific
                          time to market; potential cost saving;        networks and regional partners
                          increased success-rate of start-ups
Website                   Information exchange, access to support       SME’s, Stakeholders,General Public
                          tool, linkage to networks
Support-Tool              Validated Information on defined issues of    SME’s
                          the innovation process, access to expert
                          networks, reduction of time to market;
                          potential   cost    saving   for    product
                          development; increased success-rate of
                          start-ups
                          For REMEDY networks: fees from service        REMEDY partners, Expert networks
                          contracts – maintenance of the tool
Legal          Strategy   Contribution to European Regulation           EU Commission -           DG     Enterprise;
Paper                                                                   competent authorities
Training       Strategy   Strategy for improved training for specific   SME’s, partners in training network:
Paper                     qualifications required for TE product        universities, clinics, physicians, attorneys
                          development / production



           2
                                        REMEDY
                                       Exploitation

Training curricula   Improved training for specific qualifications   SME’s, partners in training network:
                     required for TE product development /           universities, clinics, physicians, attorneys
                     production


Ethical Manual       Increased awareness on ethical issues of        SME’s, EU Commission,         Researchers,
                     TE product development                          Ethicists, General Public,


Workshops            Awareness raising, forum for exchange of        SME, stakeholders, experts, general public
                     experiences


Knowledge            History record of case experience in TE-        SMEs; Health insurances
                     products;                                       Patient organisations;
                     Validated Information on new TE
                     developments and potential, awareness           Industry, incubators, regional development
                     International benchmark for European            agencies, researchers
                     networking activities in TE (through
                     analysing development of American TE
                     industry by FhG-ISI




        2
                       REMEDY
               Distribution of SME-users




    There are:
       start-ups
       joint-ventures
       spin-offs
       traditional SMEs
       big players

Source: Fraunhofer ISI, 2003



     2
                                               EEG                 Industrial
          KKS network Germany                                     associations


                                                                              Health
                                                                            insurance
                  KKS                                TEPS
                Tübingen




Patient
                                                 Attempto              Advisory
organi-
                  IFRM                                                  board
sations



                                                      Clifford,
                                IZEW/FhG-ISI          Chance


          REMEDY network

          Associated to REMEDY network

          External network
               REMEDY
              Exploitation


Networks


 All services are provided locally
 through local networks or incubators.
 They act as contact points between the
 local SME and the REMEDY network and
 its associated networks.


  2
                                  REMEDY Networks



                                                Network
                                                Rostock                             Region
         Region                     Health
                                                                                 Tartu, Estonia
      Skåne, Sweden               insurance


Clifford        Partner network                                                                      Patient
Chance                                         REMEDY                Partner network
                  Attempto                                                                        organisations
                                                                          IFRM
                                              Consortium
       Network                                                                             Network
       Leipzig                                                                             Tübingen
                            Partner network                 Partner network
                                 KKS                             TEPS



               CRO‘s                                                          EUCOMED, BPI
                                                Region
                                               Neckar/Alb




           2
                           European longterm innovation model
x       x       x

    x       x

SCIENTISTS
                              Ideas
                                          Funding source
o       o       o

    o       o
                                              Experts                         New projects
COMPANIES


                                     Local incubator or network


                      Business                                     Associations
                                      Legal    Clinical   Ethics
                    Administration                                 Industry know-how




                                         Business concept                  European network



                    2
     REMEDY
    Exploitation




2
     REMEDY
    Exploitation




2
                   REMEDY
                 Dissemination


Directly contacting target groups and stakeholders

Target groups:

SME
              industry associations
              scientists
              physicians
              ethicists
              health insurances
              incubators, transfer agencies
              politicians, patient groups


 2
                   REMEDY
                 Dissemination


Directly contacting target groups and stakeholders
By

              Questionnaires
              Interviews
              Website
              Workshops
              Scientific congresses
              Direct consultations
              Sotware-Tool
              Publications




 2
                   REMEDY
                 Dissemination


Directly contacting target groups and stakeholders
By

              Questionnaires
              Interviews
              Website
              Workshops
              Scientific congresses
              Direct consultations
              Sotware-Tool




 2
                   REMEDY
                 Dissemination


Directly contacting target groups and stakeholders
Organised in

              Advisory Board
              European End User Group
              Regional networks
              Associated external networks

Providing direct feedback and feedback by accompanying
research studies




 2
    REMEDY




2
    REMEDY




2
    REMEDY




2
    REMEDY




2
                              REMEDY
              Example: Model-Development/ Incubation-Phase

                                                                        Innovation step

                                                                                  Start-ups
      Normal process

      Improved process                                                            Improved Start-ups

                                                                             Innovation step


     TE
Product Matrix




                                                                                Feedback of knowledge
                                                 Pre-/Clinical   Market-Entry   and experiences for
                      Incubation   Training
 Innovation Process                                                             model-development

                               Best Practise/ Innovation networks
                            REMEDY
                        TE Product Matrix


             Autologous cells   Allogeneic cells   Xenogenous    No cells
                                                   cells

             D     AS    ES     D     AS     ES    D   AS   ES
Extra-
corporal     X                  X                  X
systems
Implanted
with
biological   X     X            X                  X             X
carrier
scaffold
Implanted
with non-
biological   X     X            X                  X             X
carrier
scaffold
Implanted
without      X     X     (X)          X      (X)                 P
carrier
scaffold


  2

				
DOCUMENT INFO